News
Azurity Pharmaceuticals, Inc. announced the recall of one lot (F230169A) of Zenzedi CII (dextroamphetamine sulfate tablets, USP) 30 milligrams on Wednesday, which the U.S. Food and Drug ...
WOBURN, Mass., March 14, 2025 /PRNewswire/ -- Azurity Pharmaceuticals ("Azurity") announced today the successful completion of its acquisition of Covis Group S.à r.l. ("Covis") from existing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback